FIG. 1 is a perspective view showing my design;
FIG. 2 is a front elevational view thereof;
FIG. 3 is a rear elevational view thereof;
FIG. 4 is a right side elevational view thereof;
FIG. 5 is a left side elevational view thereof;
FIG. 6 is a top plan view thereof; and,
FIG. 7 is a bottom plan view thereof.
The portions of the blood system cartridge shown in broken lines form no part of the claimed design.
| Patent |
Priority |
Assignee |
Title |
| 10159714, |
Feb 16 2011 |
Intarcia Therapeutics, Inc. |
Compositions, devices and methods of use thereof for the treatment of cancers |
| 10231923, |
Sep 28 2009 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery |
| 10363287, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Method of manufacturing an osmotic delivery device |
| 10441528, |
Feb 13 2008 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents |
| 10501517, |
May 16 2016 |
INTARCIA THERAPEUTICS, INC |
Glucagon-receptor selective polypeptides and methods of use thereof |
| 10527170, |
Aug 09 2006 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein |
| 10583080, |
Sep 30 2014 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| 10835580, |
Jan 03 2017 |
INTARCIA THERAPEUTICS, INC |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
| 10869830, |
Sep 28 2009 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery |
| 10925639, |
Jun 03 2015 |
INTARCIA THERAPEUTICS INC |
Implant placement and removal systems |
| 11214607, |
May 16 2016 |
Intarcia Therapeutics Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof |
| 11246913, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide |
| 11654183, |
Jan 03 2017 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of exenatide and co-administration of a drug |
| 11840559, |
May 16 2016 |
INTARCIA ASSIGNMENT FOR THE BENEFIT OF CREDITORS , LLC |
Glucagon-receptor selective polypeptides and methods of use thereof |
| 9889085, |
Sep 30 2014 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| D796688, |
Jan 09 2015 |
Butler Concepts Limited |
Storage cassette |
| D814655, |
Jul 09 2014 |
Butler Concepts Limited |
Storage cassette |
| D835783, |
Jun 02 2016 |
Intarcia Therapeutics, Inc. |
Implant placement guide |
| D840030, |
Jun 02 2016 |
INTARCIA THERAPEUTICS INC |
Implant placement guide |
| D855484, |
Sep 09 2016 |
Centrica Connected Home Limited |
Sensor |
| D860451, |
Jun 02 2016 |
INTARCIA THERAPEUTICS INC |
Implant removal tool |
| D912249, |
Jun 02 2016 |
Intarcia Therapeutics, Inc. |
Implant removal tool |
| D933219, |
Jul 13 2018 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly |
| D959017, |
Sep 30 2019 |
TOKYO OHKA KOGYO CO , LTD |
Container for cell observation |
| ER418, |
|
|
|
| ER4935, |
|
|
|
| ER9925, |
|
|
|